[go: up one dir, main page]

GB202006823D0 - Antagonist compounds - Google Patents

Antagonist compounds

Info

Publication number
GB202006823D0
GB202006823D0 GBGB2006823.5A GB202006823A GB202006823D0 GB 202006823 D0 GB202006823 D0 GB 202006823D0 GB 202006823 A GB202006823 A GB 202006823A GB 202006823 D0 GB202006823 D0 GB 202006823D0
Authority
GB
United Kingdom
Prior art keywords
antagonist compounds
antagonist
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2006823.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adorx Therapeutics Ltd
Original Assignee
Adorx Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adorx Therapeutics Ltd filed Critical Adorx Therapeutics Ltd
Priority to GBGB2006823.5A priority Critical patent/GB202006823D0/en
Publication of GB202006823D0 publication Critical patent/GB202006823D0/en
Priority to EP21726445.6A priority patent/EP4146654A1/en
Priority to BR112022022437A priority patent/BR112022022437A2/en
Priority to GB2217519.4A priority patent/GB2609879B/en
Priority to CA3181354A priority patent/CA3181354A1/en
Priority to AU2021266433A priority patent/AU2021266433A1/en
Priority to US17/923,374 priority patent/US20230203041A1/en
Priority to PH1/2022/552987A priority patent/PH12022552987A1/en
Priority to PE2022002570A priority patent/PE20230769A1/en
Priority to KR1020227042714A priority patent/KR20230035236A/en
Priority to MX2022013946A priority patent/MX2022013946A/en
Priority to JP2022567895A priority patent/JP7724239B2/en
Priority to PCT/GB2021/051106 priority patent/WO2021224636A1/en
Priority to CN202180047824.2A priority patent/CN115996929B/en
Priority to IL297963A priority patent/IL297963A/en
Priority to CL2022003055A priority patent/CL2022003055A1/en
Priority to ECSENADI202291613A priority patent/ECSP22091613A/en
Priority to CONC2022/0017618A priority patent/CO2022017618A2/en
Priority to JP2025130117A priority patent/JP2025183201A/en
Priority to IL324071A priority patent/IL324071A/en
Ceased legal-status Critical Current

Links

GBGB2006823.5A 2020-05-07 2020-05-07 Antagonist compounds Ceased GB202006823D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB2006823.5A GB202006823D0 (en) 2020-05-07 2020-05-07 Antagonist compounds
IL297963A IL297963A (en) 2020-05-07 2021-05-06 Adenosine a2a receptor antagonists
PE2022002570A PE20230769A1 (en) 2020-05-07 2021-05-06 ADENOSINE A2A RECEPTOR ANTAGONISTS
MX2022013946A MX2022013946A (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor.
GB2217519.4A GB2609879B (en) 2020-05-07 2021-05-06 Antagonists of the adenosine A2a receptor
CA3181354A CA3181354A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor
AU2021266433A AU2021266433A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine A2a receptor
US17/923,374 US20230203041A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor
PH1/2022/552987A PH12022552987A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor
EP21726445.6A EP4146654A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor
KR1020227042714A KR20230035236A (en) 2020-05-07 2021-05-06 Adenosine A2A receptor antagonists
BR112022022437A BR112022022437A2 (en) 2020-05-07 2021-05-06 ADENOSINE A2A RECEPTOR ANTAGONISTS
JP2022567895A JP7724239B2 (en) 2020-05-07 2021-05-06 Adenosine A2A receptor antagonists
PCT/GB2021/051106 WO2021224636A1 (en) 2020-05-07 2021-05-06 Antagonists of the adenosine a2a receptor
CN202180047824.2A CN115996929B (en) 2020-05-07 2021-05-06 Antagonists of adenosine A2a receptors
CL2022003055A CL2022003055A1 (en) 2020-05-07 2022-11-04 a2a adenosine receptor antagonists
ECSENADI202291613A ECSP22091613A (en) 2020-05-07 2022-12-01 ADENOSINE A2A RECEPTOR ANTAGONISTS
CONC2022/0017618A CO2022017618A2 (en) 2020-05-07 2022-12-06 a2a adenosine receptor antagonists
JP2025130117A JP2025183201A (en) 2020-05-07 2025-08-04 Adenosine A2A receptor antagonists
IL324071A IL324071A (en) 2020-05-07 2025-10-19 Antagonists of the adenosine a2a receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2006823.5A GB202006823D0 (en) 2020-05-07 2020-05-07 Antagonist compounds

Publications (1)

Publication Number Publication Date
GB202006823D0 true GB202006823D0 (en) 2020-06-24

Family

ID=71134843

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2006823.5A Ceased GB202006823D0 (en) 2020-05-07 2020-05-07 Antagonist compounds

Country Status (1)

Country Link
GB (1) GB202006823D0 (en)

Similar Documents

Publication Publication Date Title
IL300211A (en) Antagonist compounds
EP4452937A4 (en) Compounds
GB202019622D0 (en) Antagonist compounds
GB202013558D0 (en) GRP52 Modularor compounds
SG11202113345WA (en) Cgrp antagonist compounds
SG11202113348UA (en) Cgrp antagonist compounds
GB202014944D0 (en) Compounds
GB202011811D0 (en) Compounds
GB202011812D0 (en) Compounds
GB202019922D0 (en) Antagonist compounds
GB202011892D0 (en) Antagonist compounds
GB202001564D0 (en) Compounds
GB202006823D0 (en) Antagonist compounds
GB202201151D0 (en) Antagonist compounds
GB202000906D0 (en) Antagonist
GB201910865D0 (en) Antagonist compounds
GB201904158D0 (en) Antagonist compounds
GB201918392D0 (en) H4 Antagonist compounds
GB202005877D0 (en) H4 antagonist compounds
GB202005858D0 (en) H4 Antagonist compounds
GB202014255D0 (en) Compounds
GB202012802D0 (en) Compounds
GB202011924D0 (en) Compounds
GB202011537D0 (en) Compounds
GB202010862D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)